 BOULDER, Colo., Oct. 29, 2020 GLOBE NEWSWIRE -- Brickell Biotech, Inc. Brickell Nasdaq: BBI, a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced that it will report its financial results for the third quarter ended September 30, 2020, after the market close on Thursday, November 12, 2020. Brickells management will host a conference call and webcast at 4:30 pm ET on Thursday, November 12th to discuss the financial results and recent corporate highlights. 